Evrom Cannalytech
Cannabis-Specific Biostimulants Enhancing Yield and Disease Resistance
Company Overview
Snapshot
Founded in February 2023 by Onie Tsabari, Evrom Cannalytech operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of biostimulants for cannabis cultivation.
Business overview
Evrom Cannalytech specializes in developing biostimulants specifically for cannabis cultivation. The company's patent-pending formulations are designed to enhance disease resistance and increase the production of cannabinoids and terpenoids in both greenhouse and outdoor settings. By utilizing pathogen-derived compounds, these biostimulants activate the plant's defense mechanisms, leading to healthier growth and improved yields. Evrom Cannalytech operates within the Agriculture & Food Technologies sector, specifically targeting the Ag Tech and Medical Cannabis markets.
Company Intelligence Q&A
- What is Evrom Cannalytech's primary focus?
- Evrom Cannalytech specializes in the development of biostimulants tailored specifically for cannabis cultivation, aiming to enhance yield and disease resistance.
- When was Evrom Cannalytech founded?
- Evrom Cannalytech was founded in February 2023.
- Who is the founder of Evrom Cannalytech?
- Onie Tsabari is the founder of Evrom Cannalytech.
- What stage is Evrom Cannalytech currently in?
- Evrom Cannalytech is currently in the Pre-Funding stage, with its product in R&D.
- What technology does Evrom Cannalytech utilize in its products?
- Evrom Cannalytech utilizes pathogen-derived compounds in its biostimulant formulations to activate the plant's defense mechanisms, promoting healthier growth and improved yields.